Dixie Brands Inc. confirmed that, in conjunction with its manufacturer, it will launch Dixie's initial branded product offering into the Oklahoma medical cannabis market by the end of January 2020. The initial offering will be followed by a full portfolio launch, including Dixie's pioneering CBD brand AcesoHemp, in February 2020. Dixie, a pioneer in the development of infused-cannabis products since 2010, has built one of the industry's most comprehensive portfolios via a deep R&D and production heritage built over nearly a decade. With over 100 products across more than 15 different product categories, the portfolio represents one of the industry's most extensive 'House of Brands' encompassing both regulated THC and ratio brands in Dixie and Synergy and hemp-derived CBD offerings, including AcesoHemp and Therabis. Oklahoma is one of the country's growing legal cannabis markets with over 200,000 registered patients driving more than $250 million in regulated retail sales as of October 2019. With more than 5% of the state's population now registered as medical cannabis patients, exceeding any other program in the nation, the category was expected to eclipse $350 million by the end of 2019. The passing of SQ788 (the bill legalizing cannabis for medical use) provides the opportunity for licensed dispensaries to offer patients both THC and hemp-derived CBD products.